What are the possible causes of hair loss in a 66-year-old woman?

Causes of Hair Loss in a 66-Year-Old Woman

In a 66-year-old woman, the most common cause of hair loss is female pattern hair loss (FPHL), which affects approximately 50% of postmenopausal women, followed by chronic telogen effluvium, thyroid disorders, nutritional deficiencies, and less commonly, scarring alopecias like frontal fibrosing alopecia.

Primary Causes

Female Pattern Hair Loss (FPHL)

FPHL is the predominant cause at this age, with prevalence reaching 52% in postmenopausal women 1. This presents as:

• Centrifugal expansion in the mid-scalp (Ludwig pattern) - most common
• Frontal accentuation or "Christmas tree" pattern 2
• The frontal hairline typically remains preserved, distinguishing it from male pattern baldness

Key point: FPHL at age 66 is primarily driven by hormonal changes from menopause, not necessarily androgen excess. The relative increase in androgens after estrogen cessation, combined with decreased estrogen's protective effects on hair follicles, drives miniaturization 3, 4.

Chronic Telogen Effluvium (CTE)

This is the second most common differential and often coexists with FPHL 2. CTE presents as:

• Diffuse scalp thinning without the central pattern of FPHL
• Persistent generalized shedding
• Positive hair pull test from multiple scalp areas including the occiput
• Bitemporal recession may occur

Hormonal and Endocrine Causes

Evaluate for:

• Thyroid dysfunction - both hypo- and hyperthyroidism cause diffuse hair loss 2
• Elevated prolactin - can contribute to hair loss, may indicate hypothyroidism or other pathology 2
• Androgen excess - though less common at this age, sudden worsening of FPHL with virilizing signs warrants evaluation for androgen-producing tumors 5

Nutritional Deficiencies

While controversial for direct causation, deficiencies are common and may impair hair regrowth 2:

• Vitamin D deficiency - found in 62% of women with FPHL 2
• Iron deficiency - relationship uncertain in postmenopausal women; supplementation in low-normal ferritin (<70 mg/L) did not improve hair loss 2
• Zinc deficiency - present in 15% of FPHL patients 2

Scarring (Cicatricial) Alopecias

These are critical not to miss as they cause permanent hair loss:

Frontal Fibrosing Alopecia (FFA) - increasingly common in postmenopausal white women 2:

• Receding hairline with perifollicular erythema
• Eyebrow loss
• Requires scalp biopsy showing lymphocytic infiltrate

Central Centrifugal Cicatricial Alopecia (CCCA) - primarily in African American women 2:

• Central, frontal, or vertex hair loss
• Progresses to frank baldness with loss of follicular openings
• May be triggered by hair care practices (hot combs, relaxers) on underlying FPHL

Diagnostic Approach

Clinical diagnosis is primary 2. Look for:

1. Pattern of hair loss - central widening vs. diffuse vs. scarring
2. Scalp examination - follicular openings present (non-scarring) vs. absent (scarring), erythema, scaling
3. Hair pull test - positive in active shedding (CTE, telogen effluvium)
4. Dermatoscopy - increased single hair units, yellow dots (empty follicles), hair diameter variation 2

When to biopsy: If scarring alopecia suspected or diagnosis unclear after clinical exam 2

Laboratory Evaluation

Mandatory workup 2:

• Total testosterone (LC/MS preferred) and free testosterone (calculated using SHBG)
• Thyroid profile (TSH, free T4)
• Prolactin

Recommended but optional 2:

• Ferritin (iron studies)
• 25-hydroxyvitamin D
• Zinc levels

Critical caveat: In postmenopausal women, iron deficiency is NOT clearly linked to FPHL improvement with supplementation 2. However, correcting deficiencies may optimize conditions for hair regrowth.

Age-Specific Considerations

At age 66, two distinct patterns emerge 6:

1. Diffuse pattern - generalized scalp thinning correlating with body hair loss and older age
2. Frontal pattern - associated with higher facial hair scores and relatively younger postmenopausal age

Menopause-related changes 3, 4:

• Hair density decreases with age
• Hair diameter decreases, particularly in frontal scalp
• Hair growth rate slows
• Percentage of hairs in growth phase (anagen) decreases

Red Flags Requiring Urgent Evaluation

• Sudden onset or rapid progression - consider androgen-producing tumor 5
• Virilizing signs (deepening voice, clitoromegaly, increased muscle mass)
• Scalp erythema with hair loss - suggests scarring alopecia requiring biopsy
• Underlying breast cancer or other malignancy - alopecia neoplastica (tumor metastasis to scalp) 5

Common Pitfalls

• Assuming all hair loss is "just aging" - FPHL is treatable and early intervention prevents progression
• Missing scarring alopecias - these cause permanent follicle destruction; biopsy when uncertain
• Over-supplementing iron - no proven benefit in postmenopausal women without true deficiency 2
• Failing to distinguish FPHL from CTE - they often coexist but have different prognoses 5